ALBANO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 12.719
EU - Europa 6.010
AS - Asia 5.372
SA - Sud America 1.390
AF - Africa 309
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 25.807
Nazione #
US - Stati Uniti d'America 12.528
SG - Singapore 2.248
DE - Germania 2.153
CN - Cina 1.131
BR - Brasile 1.080
RU - Federazione Russa 918
HK - Hong Kong 700
SE - Svezia 634
IT - Italia 619
GB - Regno Unito 534
VN - Vietnam 363
FR - Francia 330
FI - Finlandia 309
IN - India 191
UA - Ucraina 143
BD - Bangladesh 127
CI - Costa d'Avorio 113
AR - Argentina 108
ID - Indonesia 106
CA - Canada 88
IQ - Iraq 77
ZA - Sudafrica 71
PK - Pakistan 63
MX - Messico 59
JP - Giappone 57
PL - Polonia 56
CO - Colombia 47
TR - Turchia 47
BE - Belgio 43
EC - Ecuador 40
VE - Venezuela 39
ES - Italia 35
IE - Irlanda 35
NL - Olanda 34
AT - Austria 31
SA - Arabia Saudita 31
PH - Filippine 29
TN - Tunisia 28
CL - Cile 27
MA - Marocco 27
CZ - Repubblica Ceca 25
UZ - Uzbekistan 24
MY - Malesia 20
PE - Perù 19
JO - Giordania 18
LT - Lituania 18
NP - Nepal 17
KE - Kenya 15
PY - Paraguay 15
EG - Egitto 14
RO - Romania 14
KZ - Kazakistan 13
ET - Etiopia 12
RS - Serbia 12
AZ - Azerbaigian 10
CH - Svizzera 9
IR - Iran 9
JM - Giamaica 9
KG - Kirghizistan 9
KR - Corea 9
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 8
TH - Thailandia 8
AL - Albania 7
CR - Costa Rica 7
IL - Israele 7
LB - Libano 7
PS - Palestinian Territory 7
GR - Grecia 6
BH - Bahrain 5
HU - Ungheria 5
PA - Panama 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
GE - Georgia 4
HN - Honduras 4
HR - Croazia 4
MD - Moldavia 4
MU - Mauritius 4
NI - Nicaragua 4
OM - Oman 4
SN - Senegal 4
AU - Australia 3
BY - Bielorussia 3
CY - Cipro 3
MT - Malta 3
QA - Qatar 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
CG - Congo 2
EE - Estonia 2
GA - Gabon 2
GT - Guatemala 2
KH - Cambogia 2
Totale 25.769
Città #
Fairfield 1.541
Ashburn 1.397
Singapore 1.187
Woodbridge 896
Chandler 835
Houston 723
San Jose 706
Hong Kong 695
Seattle 672
Cambridge 529
Nyköping 517
Wilmington 460
Beijing 380
New York 374
Ann Arbor 351
Jacksonville 308
Los Angeles 246
Lauterbourg 205
Lawrence 181
Roxbury 176
Helsinki 165
Bari 141
Munich 134
Dallas 129
Nanjing 117
Abidjan 112
Ho Chi Minh City 109
Council Bluffs 106
Des Moines 106
Brooklyn 104
Falkenstein 90
São Paulo 85
Princeton 83
Jakarta 79
Boardman 69
Santa Clara 69
Inglewood 63
Hanoi 62
San Diego 62
London 60
Buffalo 58
Moscow 56
Frankfurt am Main 52
Dong Ket 50
Tokyo 49
Paris 45
Warsaw 44
Brussels 42
Chicago 38
Redwood City 38
Rio de Janeiro 38
Nanchang 37
Turku 37
Nuremberg 36
Johannesburg 35
Atlanta 34
Denver 34
Dublin 33
Montreal 32
Rome 31
Belo Horizonte 30
Shenyang 30
Baghdad 29
Chennai 29
Milan 29
Columbus 27
Jiaxing 27
Marseille 27
Changsha 26
Dearborn 26
Dhaka 26
Tianjin 26
Pune 25
The Dalles 25
Hebei 24
Guangzhou 23
Orem 23
Shanghai 22
Tashkent 22
Brasília 21
Mexico City 21
San Francisco 21
Lahore 19
Phoenix 19
Boston 18
Poplar 18
Mumbai 17
Curitiba 16
Falls Church 16
Quito 16
Salvador 16
Stockholm 16
Toronto 16
Campinas 15
Porto Alegre 15
Portsmouth 15
Salt Lake City 15
Amsterdam 14
Guayaquil 14
Nairobi 14
Totale 15.991
Nome #
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 251
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 244
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 227
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 218
Monosomal karyotype in myeloid neoplasias: a literature review 217
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 213
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 207
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 207
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 206
A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma 201
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 200
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 196
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 195
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 193
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 192
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 187
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 187
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 185
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 182
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 182
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 182
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 181
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 180
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 179
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia 178
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy 177
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 174
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 170
Non-treatment-related chronic myeloid leukemia as a second malignancy 168
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 166
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 165
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 165
Decreased TET2 gene expression during chronic myeloid leukemia progression 164
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 164
Iron chelation therapy induces hematological response in transfusion dependent patient with myeloid malignancies 164
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 162
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 161
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 161
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 161
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene 160
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 159
Similar mechanisms formed ring markers containing chromosome 12 pericentromeric region in two patients with therapy-related acute myeloid leukemia 159
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 159
Concomitant occurrence of BCR-ABL and JAK2V617F mutation 158
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 158
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 158
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 158
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 156
Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients 156
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 155
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 153
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 152
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 151
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 150
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma 150
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 150
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 149
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 148
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 148
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 147
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 146
Differences among young adults, adults, and elderly chronic myeloid leukemia patients. 146
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 146
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 146
Bone marrow ectopic expression of a non-coding RNA in childhood T-cell acute lymphoblastic leukemia with a novel t(2;11)(q11.2;p15.1) translocation 145
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 143
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 143
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 140
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a PH-positive chronic myeloid leukemia 139
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 139
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 139
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia 137
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 136
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 136
Retinal abnormalities in newly diagnosed adult acute myeloid leukemia 136
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 135
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 135
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile. 134
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. 134
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 134
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 132
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients 131
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto 131
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 131
Analysis of percent identity of IGHV mutation as prognostic factor in CLL patients treated with fludarabine, cyclofosfamide and rituximab: a single centre experience 131
Concomitant tetrasomy 3q and trisomy 18 in CD5- CD13+ chronic lymphocytic leukemia 130
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 130
After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia 130
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP 129
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia 129
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 128
SETBP1 dysregulation in congenital disorders and myeloid neoplasms 128
FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients 128
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial 127
A rare case of IgM-Multiple Myeloma 127
Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia 126
Characterization of der(9) deletions in CML patients 125
Droplet Digital PCR Analysis for Diagnosis and Minimal Residual Disease Monitoring in Adult Ph plus Acute Lymphoblastic Leukemia 124
RUNX1 gene alterations characterized by allelic preference in adult acute myeloid leukemia 124
Extramedullary disease in acute promyelocytic leukemia: two-in-one disease. 123
Totale 15.899
Categoria #
all - tutte 106.704
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.704


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021546 0 0 0 0 0 0 0 0 0 247 140 159
2021/20221.410 127 137 19 34 65 132 70 58 122 124 223 299
2022/20232.244 308 307 157 153 228 315 38 270 347 11 49 61
2023/20241.070 79 138 56 58 106 406 24 43 5 29 17 109
2024/20254.090 152 68 263 178 156 339 509 352 185 251 560 1.077
2025/20268.064 1.177 402 613 1.027 1.117 541 1.010 280 1.056 841 0 0
Totale 26.531